In HNSCC, Prince et al. first described the presence of a small fraction of CD44-positive cells capable of generating new tumors when inoculated in immunocompromised mice and re-establishing original tumor heterogeneity[19]. The gene discussed is CD44; the disease is head and neck squamous cell carcinoma.